Phase II multicenter study of abiraterone acetate (AA) plus prednisone therapy in docetaxel-treated castration-resistant prostate cancer (CRPC) patients (pts): Impact of prior ketoconazole (keto) Meeting Abstract
| Authors: | Danila, D. C.; de Bono, J.; Ryan, C. J.; Denmeade, S.; Smith, M.; Taplin, M.; Bubley, G.; Molina, A.; Haqq, C.; Scher, H. I. |
| Abstract Title: | Phase II multicenter study of abiraterone acetate (AA) plus prednisone therapy in docetaxel-treated castration-resistant prostate cancer (CRPC) patients (pts): Impact of prior ketoconazole (keto) |
| Meeting Title: | 45th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 27 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2009 May 29-Jun 2 |
| Meeting Location: | Orlando, FL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2009-05-20 |
| Start Page: | 246s |
| Language: | English |
| ACCESSION: | WOS:000276606603449 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2009.27.15_suppl.5048 |
| Notes: | Meeting Abstract: 5048 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
